1. Home
  2. EVO vs SAFE Comparison

EVO vs SAFE Comparison

Compare EVO & SAFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • SAFE
  • Stock Information
  • Founded
  • EVO 1993
  • SAFE 2016
  • Country
  • EVO Germany
  • SAFE United States
  • Employees
  • EVO N/A
  • SAFE N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • SAFE Real Estate Investment Trusts
  • Sector
  • EVO Health Care
  • SAFE Real Estate
  • Exchange
  • EVO Nasdaq
  • SAFE Nasdaq
  • Market Cap
  • EVO 1.4B
  • SAFE 1.2B
  • IPO Year
  • EVO 2021
  • SAFE 2017
  • Fundamental
  • Price
  • EVO $4.15
  • SAFE $14.55
  • Analyst Decision
  • EVO Strong Buy
  • SAFE Buy
  • Analyst Count
  • EVO 1
  • SAFE 8
  • Target Price
  • EVO $7.00
  • SAFE $19.88
  • AVG Volume (30 Days)
  • EVO 42.9K
  • SAFE 309.2K
  • Earning Date
  • EVO 11-05-2025
  • SAFE 11-05-2025
  • Dividend Yield
  • EVO N/A
  • SAFE 4.86%
  • EPS Growth
  • EVO N/A
  • SAFE N/A
  • EPS
  • EVO N/A
  • SAFE 1.43
  • Revenue
  • EVO $912,894,891.00
  • SAFE $393,596,000.00
  • Revenue This Year
  • EVO N/A
  • SAFE $0.58
  • Revenue Next Year
  • EVO $10.78
  • SAFE $4.98
  • P/E Ratio
  • EVO N/A
  • SAFE $10.18
  • Revenue Growth
  • EVO N/A
  • SAFE 2.22
  • 52 Week Low
  • EVO $2.84
  • SAFE $13.43
  • 52 Week High
  • EVO $5.64
  • SAFE $23.90
  • Technical
  • Relative Strength Index (RSI)
  • EVO 63.61
  • SAFE 35.76
  • Support Level
  • EVO $4.05
  • SAFE $15.30
  • Resistance Level
  • EVO $4.27
  • SAFE $15.84
  • Average True Range (ATR)
  • EVO 0.09
  • SAFE 0.38
  • MACD
  • EVO 0.01
  • SAFE -0.07
  • Stochastic Oscillator
  • EVO 73.91
  • SAFE 4.04

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About SAFE Safehold Inc. New

Safehold Inc is a REIT that operates its business by acquiring, managing, and capitalizing ground leases. Ground leases are long-term contracts between the landlord (the Company) and a tenant or leaseholder. Ground leases generally represent ownership of the land underlying commercial real estate projects that are net leased by the fee owner of the land to the owners/operators of the real estate projects built thereon.

Share on Social Networks: